SIGI
DNA icon

Susquehanna International Group (Ireland)’s Ginkgo Bioworks DNA Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-506
Closed -$23.5K – 91
2024
Q1 		$23.5K Buy
+506
New +$26.2K 0.01% 76

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Susquehanna International Group (Ireland)'s DNA Position: Q2 2024 in Review

Susquehanna International Group (Ireland) sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 506 shares — an estimated $23.5K sold.

Susquehanna International Group (Ireland) first reported a position in DNA in Q1 2024 and held it in 1 quarter. The position peaked at $23.5K in Q1 2024. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Susquehanna International Group (Ireland) reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 506 Ginkgo Bioworks shares in Q2 2024, an estimated $23.5K.
  • Susquehanna International Group (Ireland) first reported a position in Ginkgo Bioworks in Q1 2024 and held it in 1 quarter.
  • Susquehanna International Group (Ireland)'s Ginkgo Bioworks position peaked at $23.5K in Q1 2024.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q2 2024, filed 15 Aug 2024.